Zhiyu Dai
Has grant
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Recent Grants
Grant: Close
Role of Alveolar Epithelium and Endothelium Interaction in Tobacco Smoke-induced Pulmonary Hypertension associated with Chronic Obstructive Lung Disease
Open Date: 2023-01-01
Close Date: 2026-01-01
Grant: Close
Arterial Endothelium Programming in Pulmonary Arterial Hypertension
Open Date: 2022-06-01
Close Date: 2024-05-01
Grant: Open
Role of Endothelial SOX17 Deficiency in the Pathogenesis of Pulmonary Hypertension
Open Date: 2022-03-01
Close Date: 2027-02-01
Grant: Close
Role of Endothelial Fatty Acid Binding Proteins in the Pathogenesis of PAH
Open Date: 2020-07-01
Close Date: 2023-06-30
Grant: Close
Endothelial fatty acid binding proteins in the pathogenesis of PAH
Open Date: 2020-07-01
Close Date: 2023-06-01
Articles (18)
Year:
2025
Year:
2025
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Transmembrane protein 100 (TMEM100) is a crucial factor in the development and maintenance of the vascular system. The protein is involved in several processes such as angiogenesis, vascular morphogenesis, and integrity. Furthermore, TMEM100 is a downstream target of the BMP9/10 and BMPR2/ALK1 signaling pathways, which are key regulators of vascular development. Our recent studies have shown that TMEM100 is a lung endothelium enriched gene and plays a significant role in lung vascular repair and regeneration. The importance of TMEM100 in endothelial cells’ regeneration was demonstrated when Tmem100 was specifically deleted in endothelial cells, causing an impairment in their regenerative ability. However, the role of TMEM100 in various conditions and diseases is still largely unknown, making it an interesting area of research. This review summarizes the current knowledge of TMEM100, including its expression pattern, function, molecular signaling, and clinical implications, which could be valuable in the development of novel therapies for the treatment of cardiovascular and pulmonary diseases.
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2021
Year:
2021
Year:
2021
Year:
2020
Collaborators (6)
Yixin Xie
Assistant Professor
Kennesaw State University
Colin Evans
University of South Carolina
Duncan Stewart
Professor
University of Ottawa
Yibin Wang
Professor
Duke University School of Medicine
Rebecca R. Vanderpool
Assistant Professor
Ohio State University
YOU-YANG ZHAO
Northwestern University Feinberg School of Medicine
Make your next move.
Prepare your application
Review drafts before you send them.